Profusa, Inc. (PFSA)

NASDAQ: PFSA · USD

$0.76

-0.02 (-2.0%)· Recorded snapshot

Market cap	462.7K
Net income (ttm)	-43M
EPS (ttm)	-$1,984
Shares out	605.6K
Volume	253,461
Beta	0.50

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -43M
EPS (ttm): -$1,984
Market cap: 462.7K

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Mantener

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROICn/a

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All PFSA indicators

Market & fundamental data

Available fields

161

Groups with data

Currency

USD

Showing 161 of 161 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001859807
Company name	Profusa, Inc.
Country	United States
Country code	US
CUSIP number	74319X405
Earnings date	2026-11-18
Earnings time	amc
Employees	15
Enterprise value	$13.8M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2009
Industry	Medical Devices
Is primary listing	Yes
Is SPAC	No
ISIN number	US74319X4051
Last 10-K release date	2026-04-15
Last earnings date	2026-08-20
Last refreshed	2026-10-28
Last stock split date	2026-08-17
Last stock split type	Reverse
Market cap	$462,714
Market cap category	Nano-Cap
Next earnings date	2026-11-18
Options	No
Price	$0.76
Price currency	USD
Sector	Healthcare
SIC code	3841
Stock price date	2026-10-28
Symbol	PFSA
U.S. state	California
Website	https://profusa.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-259,653.09%
FCF / EV yield	-147.46%
FCF yield	-4,433.11%
Industry forward P/E	19.81x
Industry P/E	39.5x
Sector forward P/E	23.56x
Sector P/E	50.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Profit per employee	$-2.9M
ROA	-725.26%
ROA (5Y)	-205.87%
ROCE	117.35%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	4
EPS growth years	1
Net income growth years	0
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-86,000
Depreciation and amortization	$2,000
EBIT	$-31.8M
EPS	$-1,983.75
FCF per share	$-33.71
Financing cash flow	$21.9M
Free cash flow	$-20.4M
Free cash flow minus SBC	$-21.6M
Investing cash flow	$-936,000
Net borrowing	$17.1M
Net cash flow	$680,000
Net income	$-43M
Operating cash flow minus SBC	$-21.5M
Operating income	$-31.8M
Stock-based compensation	$1.2M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	$-205.03
Interest coverage	-6.03
Long-term assets	$201,000
Long-term liabilities	$2,000
Net cash (debt)	$-13.4M
Net cash / market cap	-2,906.41%
Piotroski F-Score	2
Property, plant and equipment	$154,000
Shareholders' equity	$-27.1M
Tangible book value	$-27.1M
Tangible book value per share	$-205.03
Total assets	$1M
Total cash	$719,000
Total debt	$14.1M
Total liabilities	$28.2M
WACC	28.84%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current assets	$841,000
Current liabilities	$28.2M
Current ratio	0.03
Net working capital	$-13.9M
Quick ratio	0.03
Working capital	$-27.3M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$23.61
1D price change	-1.99%
1M price change	-65.13%
1M total return	-65.13%
1W price change	-14.1%
1W total return	-14.1%
1Y price change	-99.97%
1Y return CAGR	-99.97%
1Y total return	-99.97%
20-day SMA	$1.20
200-day SMA	$101.29
3M price change	-84.42%
3M total return	-84.42%
3Y price change	-100%
3Y return CAGR	-97.89%
3Y total return	-100%
50-day SMA	$2.46
50-day SMA vs 200-day SMA	50under200
52-week high	$3,000.01
52-week high date	2025-10-29
52-week low	$0.70
52-week low date	2026-10-28
6M price change	-98.52%
6M total return	-98.52%
All-time high	$97,500.24
All-time high date	2024-05-21
All-time low	$0.70
All-time low date	2026-10-21
Average true range (ATR)	$0.38
Average volume	2.8M
Beta (1Y)	3.62
Beta (2Y)	1.16
Beta (5Y)	0.5
Change from 52-week high	-99.97%
Change from 52-week low	9.14%
Change from all-time high	-100%
Change from all-time low	8.6%
Change from open	1.62%
Day's gap	-3.55%
Dollar volume	$193,644
High price	$0.76
Low price	$0.70
Monthly RSI	9.57
Open price	$0.75
Position in 52-week range	100%
Premarket change	-3.62%
Premarket close	$0.78
Premarket price	$0.75
Premarket volume	43.3K
Previous close	$0.78
Price vs 150-day SMA	-96.78%
Price vs 20-day SMA	-36.81%
Price vs 200-day SMA	-99.25%
Price vs 50-day SMA	-69.11%
Relative volume	0.09
RSI	36.7
Sharpe ratio	-0.34
Sortino ratio	-1.14
Volume	253.5K
Weekly RSI	12.12
YTD price change	-99.9%
YTD total return	-99.9%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	518.2K
Float percentage	85.56%
Shares change (QoQ)	241.66%
Shares held by insiders	14.4%
Shares held by institutions	0.48%
Shares outstanding	605.6K
Short % of float	31%
Short % of shares	26.53%
Short ratio	0 days

Deeper analysis on PFSA

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this PFSA report

Is a complete PFSA research report available?

No complete published report is available for Profusa, Inc. (PFSA) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Profusa, Inc. (PFSA)

Price

Financial snapshot

Fair-value bridge

Latest news · PFSA

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All PFSA indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on PFSA

Frequently asked questions